Testing effectiveness (Phase 2)Ended earlyNCT02855086
What this trial is testing
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Who this might be right for
Brain NeoplasmMalignant Glioma
Eben Rosenthal 3